Clinical Trial

Serum Collection Study for Assay Development

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 3, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Trial Details
NCT Number NCT07205289
Lead Sponsor GPN Vaccines
Conditions Pneumococcal Disease, Invasive, Pneumococcal Disease
Enrollment 12 participants
Start Date 2025-10
Primary Completion 2026-01 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-10-03